Nutritional Prehabilitation to Improve Cancer Outcomes (N-PICO)
N-PICO
1 other identifier
interventional
240
1 country
1
Brief Summary
Brief Summary The goal of this clinical trial is to evaluate the acceptability and adherence of low- and high-intensity remote nutritional interventions for cancer patients in rural and urban areas, specifically focusing on those with invasive cancer who are about to start treatment. The main question\[s\] it aims to answer are: Can low- and high-intensity remote nutritional interventions improve adherence to cancer treatment and quality of life? What is the impact of nutritional support on treatment delays, unplanned healthcare utilization, and dietary modifications? Researchers will compare the low-intensity arm (initial nutritional consultation plus written materials) to the high-intensity arm (1-hour consultation, monthly follow-ups, and written materials) to see if higher intensity interventions lead to better outcomes in terms of adherence, quality of life, and healthcare utilization. Participants will: Receive either a low- or high-intensity nutritional consultation. Complete surveys assessing quality of life, dietary habits, treatment delays, and unplanned healthcare use. Be asked to participate in monthly follow-up consultations (for the high-intensity group) to track progress and provide additional support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2025
CompletedFirst Posted
Study publicly available on registry
July 18, 2025
CompletedStudy Start
First participant enrolled
September 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
February 5, 2026
February 1, 2026
2.6 years
May 22, 2025
February 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Adherence to Assigned Nutritional Intervention (Low- vs. High-Intensity)
Adherence will be assessed over the 6-week intervention period using two metrics: 1. Proportion of scheduled dietary counseling contacts completed (≥70% completion threshold), and 2. Participant self-report of meeting ≥70% of individualized nutrition goals, recorded weekly. Adherence will be summarized as the percentage of participants in each arm who meet both criteria. Unit of Measure: Percentage of participants meeting adherence threshold (%)
6 months
Acceptability of Nutritional Intervention Based on Participant Survey
Acceptability will be measured at the end of the 6-week intervention using a structured participant survey developed for the study. This survey includes Likert-scale questions (e.g., ease of use, satisfaction, perceived helpfulness) and open-ended feedback. Responses will be analyzed to compare acceptability between low- and high-intensity intervention arms. Unit of Measure: Mean score on acceptability survey
6 months
Secondary Outcomes (4)
Change in Quality of Life Measured by the PROMIS Global Health Scale
6 months
Patient-Reported Dietary Behavior Change
Unit of Measure: Proportion of participants reporting positive dietary change (%)
Frequency of Treatment Delays or Modifications During Chemoradiation
6 months
Unplanned Healthcare Utilization (ER Visits and Unplanned Hospitalizations)
6 months
Study Arms (6)
Rural, Remote, Low-Intensity
EXPERIMENTALRural, Remote, Low-Intensity
Rural, Remote, High-Intensity
EXPERIMENTALRural, Remote, High-Intensity
Urban, Remote, Low-Intensity
EXPERIMENTALUrban, Remote, Low-Intensity
Urban, Remote, High-Intensity
EXPERIMENTALUrban, Remote, High-Intensity
Urban, In-Person, Low-Intensity
EXPERIMENTALUrban, In-Person, Low-Intensity
Urban, In-Person, High-Intensity
EXPERIMENTALUrban, In-Person, High-Intensity
Interventions
Participants will either receive High or Low intensity nutritional support.
Patients will either receive their support in-person or remotely.
Eligibility Criteria
You may qualify if:
- Diagnosis of invasive cancer with plans to initiate chemo-, immune-, targeted-, or hormonal therapy for treatment of their malignancy, or within one month of starting treatment.
- Age ≥ 18 years of age.
- Patients must be able to read, write, and speak English as study material and virtual nutrition consultation calls are only available in English.
- Patients receiving treatment at a participating ambulatory medical oncology site.
- Willingness to have a remote nutritional consultation and complete questionnaires/surveys.
- Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines.
You may not qualify if:
- Diagnosis of acute leukemia (these patients generally receive predominantly inpatient care).
- Diagnosis of head \& neck cancer, esophageal cancer, gastric cancer, patients presenting with recognized cachexia or severe malnutrition, or patients with PEG tubes for enteral feeding.
- Rationale: These patients would normally be referred for dietary consultation and may need ongoing clinical intervention from an on-site dietitian beyond the period of the proposed study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Vermont Medical Center
Burlington, Vermont, 05401, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director-Faculty
Study Record Dates
First Submitted
May 22, 2025
First Posted
July 18, 2025
Study Start
September 10, 2025
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
February 5, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Anonymized patient related data will be incorporated into publications and will be made available to other investigators at reasonable request.